Publications

Modelling outcomes to evaluate benefit of early treatment.

HORTON, K;

2023

(2023).

Ending TB in South-East Asia: flagship priority and response transformation.

Bhatia, V; Rijal, S; Sharma, M; Islam, A; VASSALL, A; Bhargava, A; Thida, A; Basri, C; Onozaki, I; Pai, M; Rezwan, MK; Arinaminpathy, N; Chandrashekhar, P; Sarin, R; Mandal, S; Raviglione, M;

2023

The Lancet regional health. Southeast Asia, (2023).18, 10.1016/j.lansea.2023.100301.

The Evolution and Transmission Dynamics of Multidrug-Resistant Tuberculosis in an Isolated High-Plateau Population of Tibet, China.

Jiang, Q; Liu, H-C; Liu, Q-Y; PHELAN, JE; Tao, F-X; Zhao, X-Q; Wang, J; GLYNN, JR; Takiff, HE; CLARK, TG; Wan, K-L; Gao, Q;

2023

Microbiology spectrum, (2023).11 2 10.1128/spectrum.03991-22.

Journey of the tuberculosis patients in India from onset of symptom till one-year post-treatment. Complete dataset.

Chatterjee, S; Das, P; Shikhule, A; Munje, R; VASSALL, A;

2023

, PLOS Global Public Health (2023).

Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV.

ELLIS, J; Bangdiwala, AS; Skipper, CP; Tugume, L; Nsangi, L; Matovu, J; Pastick, KA; Ssebambulidde, K; Morawski, BM; Musubire, AK; Schleiss, MR; MOORE, DA J; JARVIS, JN; Boulware, DR; Meya, DB; Castelnuovo, B;

2023

Open Forum Infectious Diseases, (2023).10 9 10.1093/ofid/ofad449.

Prevalence of subclinical pulmonary tuberculosis and its association with HIV in household contacts of index tuberculosis patients in two South African provinces: a secondary, cross-sectional analysis of a cluster-randomised trial.

Carter, N; WEBB, EL; Lebina, L; Motsomi, K; Bosch, Z; Martinson, NA; MacPherson, P;

2023

BMC Global and Public Health, (2023).1 1 10.1186/s44263-023-00022-5.

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.

Nyang'wa, B-T; Berry, C; Kazounis, E; Motta, I; Parpieva, N; Tigay, Z; Moodliar, R; DODD, M; Solodovnikova, V; Liverko, I; Rajaram, S; Rassool, M; McHugh, T; Spigelman, M; MOORE, DA; Ritmeijer, K; Du Cros, P; FIELDING, K; TB-PRACTECAL team,;

2023

The Lancet. Respiratory medicine, (2023).12 2 10.1016/s2213-2600(23)00389-2.

Diagnostic performance of host protein signatures as a triage test for active pulmonary TB.

Koeppel, L; Denkinger, CM; Wyss, R; Broger, T; Chegou, NN; Dunty, JM; Scott, K; Cáceres, T; Dutoit, E; Ugarte-Gil, C; Nicol, M; Gotuzzo, E; Corstjens, PL A M; Geluk, A; SUTHERLAND, J; Sigal, GB; Moreau, E; Albertini, A; Mantsoki, A; Ongarello, S; Walzl, G; Fernandez Suarez, M;

2023

Journal of clinical microbiology, (2023).61 10 10.1128/jcm.00264-23.

Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity.

Eckold, C; Van Doorn, CL R; DOCKRELL, H; Ottenhoff, TH M; Vianello, E; Cliff, JM;

2023

, NCBI Gene Expression Omnibus (2023).

Feasibility and acceptability of undertaking postmortem studies for tuberculosis medical research in a low income country.

Ahimbisibwe, G; Nakibuule, M; Martin Ssejoba, M; Oyamo, D; Mulwana, R; Nabulime, J; Babirye, F; Kizito, MA; Lekuya, HM; Adakun, AS; Nalumansi, D; Muryasingura, S; Lukande, R; Kyazze, A; Baluku, JB; Biraro, IA; COSE, S;

2023

Frontiers in immunology, (2023).14, 10.3389/fimmu.2023.1264351.